Hepatitis B vaccine - Bharat BiotechAlternative Names: Hepatitis B recombinant vaccine - Bharat Biotech; Revac-B+; Revac-Bmcf
Latest Information Update: 17 Feb 2016
At a glance
- Originator Bharat Biotech
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis B
Most Recent Events
- 17 Feb 2016 Bharat Biotech files for a patent protection for Himax technology (Bharat Biotech; February 2016)